Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
68.51
+0.81 (1.20%)
At close: Jun 27, 2025, 4:00 PM
68.45
-0.06 (-0.09%)
After-hours: Jun 27, 2025, 7:59 PM EDT
Novo Nordisk Employees
As of December 31, 2024, Novo Nordisk had 77,349 total employees, including 76,302 full-time and 1,047 part-time employees. The number of employees increased by 13,030 or 20.26% compared to the previous year.
Employees
77,349
Change (1Y)
13,030
Growth (1Y)
20.26%
Revenue / Employee
$567,845
Profits / Employee
$195,965
Market Cap
331.06B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 77,349 | 13,030 | 20.26% |
Dec 31, 2023 | 64,319 | 9,134 | 16.55% |
Dec 31, 2022 | 55,185 | 6,707 | 13.84% |
Dec 31, 2021 | 48,478 | 3,155 | 6.96% |
Dec 31, 2020 | 45,323 | 2,065 | 4.77% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
NVO News
- 1 day ago - Health Rounds: Novo Nordisk's semaglutide may help some with type 1 diabetes - Reuters
- 2 days ago - Novo Nordisk to Expand Access to Wegovy with WeightWatchers Partnership - WSJ
- 2 days ago - Novo Nordisk ties up with WeightWatchers to sell Wegovy - Reuters
- 2 days ago - Novo Nordisk continues efforts to support patient access to authentic, FDA approved Wegovy® and prioritize patient safety - PRNewsWire
- 2 days ago - Lilly to launch Mounjaro pen in India to compete with Novo's Wegovy - Reuters
- 2 days ago - Weight loss and diabetes jabs linked to potentially fatal side effect - Skynews
- 3 days ago - NVO Investors Have Opportunity to Join Novo Nordisk A/S Fraud Investigation with the Schall Law Firm - Business Wire
- 3 days ago - The Best European Stocks to Buy - Kiplinger